Pregnant Women: Based on the rare occurrence of hemophilia A in women, experience regarding the use of factor VIII during pregnancy is not available. Xyntha should be administered to pregnant women only if the benefit outweighs the risk.
Breast-feeding: No animal reproduction and lactation studies have been conducted with Xyntha. Xyntha should be administered to lactating women only if the benefit outweighs the risk.